-
1 . Academic Journal
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
- 저자
- by Aggarwal, P.; Aglawe, V.; Ali, A.; Anand, N.; Awad, N., et al.
- 소스
- In The Lancet 11-17 December 2021 398(10317):2173-2184
-
7 . Periodical
Efficacy, safety, and lot-to-lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): interim results of a randomised, double-blind, controlled, phase 3 trial
- 저자
- by Ella, Raches; Reddy, Siddarth; Blackwelder, William; Potdar, Varsha; Yadav, Pragya, et al.
- 소스
- The Lancet; December 2021, Vol. 398 Issue: 10317 p2173-2184, 12p